{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:57:26Z","timestamp":1781535446666,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00259-015-3039-0","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T01:51:17Z","timestamp":1427593877000},"page":"1062-1070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Brain 18F-DOPA PET and cognition in de novo Parkinson\u2019s disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Agnese","family":"Picco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Piccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Girtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brugnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bossert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Campus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Abbruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"key":"3039_CR1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol. 2010;9:1200\u201313.","journal-title":"Lancet Neurol"},{"key":"3039_CR2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11910-012-0312-5","volume":"12","author":"DO Claassen","year":"2012","unstructured":"Claassen DO, Wylie SA. Trends and issues in characterizing early cognitive changes in Parkinson\u2019s disease. Curr Neurol Neurosci Rep. 2012;12:695\u2013702.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3039_CR3","doi-asserted-by":"crossref","first-page":"1127.e11","DOI":"10.1016\/j.neurobiolaging.2011.11.028","volume":"33","author":"D Arnaldi","year":"2012","unstructured":"Arnaldi D, Campus C, Ferrara M, et al. What predicts cognitive decline in de novo Parkinson\u2019s disease? Neurobiol Aging. 2012;33:1127.e11\u201320.","journal-title":"Neurobiol Aging"},{"key":"3039_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.0000000000000034","volume":"82","author":"KT Olde Dubbelink","year":"2014","unstructured":"Olde Dubbelink KT, Hillebrand A, Twisk JW, et al. Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers. Neurology. 2014;82:263\u201370.","journal-title":"Neurology"},{"key":"3039_CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone P. Neurotransmission in Parkinson\u2019s disease: beyond dopamine. Eur J Neurol. 2010;17:364\u201376.","journal-title":"Eur J Neurol"},{"key":"3039_CR6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","volume":"95","author":"DJ Brooks","year":"2011","unstructured":"Brooks DJ, Pavese N. Imaging biomarkers in Parkinson\u2019s disease. Prog Neurobiol. 2011;95:614\u201328.","journal-title":"Prog Neurobiol"},{"key":"3039_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","volume":"11","author":"AA Kehagia","year":"2013","unstructured":"Kehagia AA, Barker RA, Robbins TW. Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis. Neurodegener Dis. 2013;11:79\u201392.","journal-title":"Neurodegener Dis"},{"key":"3039_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(98)00928-8","volume":"260","author":"RM Mari\u00e9","year":"1999","unstructured":"Mari\u00e9 RM, Barr\u00e9 L, Dupuy B, et al. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson\u2019s disease. Neurosci Lett. 1999;260:77\u201380.","journal-title":"Neurosci Lett"},{"key":"3039_CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archneur.57.4.470","volume":"57","author":"JO Rinne","year":"2000","unstructured":"Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol. 2000;57:470\u20135.","journal-title":"Arch Neurol"},{"key":"3039_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)02124-3","volume":"311","author":"A Br\u00fcck","year":"2001","unstructured":"Br\u00fcck A, Portin R, Lindell A, et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson\u2019s disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett. 2001;311:81\u20134.","journal-title":"Neurosci Lett"},{"key":"3039_CR11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2006.03.004","volume":"59","author":"VL Cropley","year":"2006","unstructured":"Cropley VL, Fujita M, Innis RB, et al. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol Psychiatry. 2006;59:898\u2013907.","journal-title":"Biol Psychiatry"},{"key":"3039_CR12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jns.2006.05.033","volume":"248","author":"M Beilen van","year":"2006","unstructured":"van Beilen M, Leenders KL. Putamen FDOPA uptake and its relationship to cognitive functioning in PD. J Neurol Sci. 2006;248:68\u201371.","journal-title":"J Neurol Sci"},{"key":"3039_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2008.03.005","volume":"15","author":"P Jokinen","year":"2009","unstructured":"Jokinen P, Br\u00fcck A, Aalto S, et al. Impaired cognitive performance in Parkinson\u2019s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord. 2009;15:88\u201393.","journal-title":"Parkinsonism Relat Disord"},{"key":"3039_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mds.22899","volume":"25","author":"F Nobili","year":"2010","unstructured":"Nobili F, Campus C, Arnaldi D, et al. Cognitive-nigrostriatal relationships in de novo, drug-na\u00efve Parkinson\u2019s disease patients: a [I-123]FP-CIT SPECT study. Mov Disord. 2010;25:35\u201343.","journal-title":"Mov Disord"},{"key":"3039_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2013.03.006","volume":"329","author":"P Jokinen","year":"2013","unstructured":"Jokinen P, Karrasch M, Br\u00fcck A, et al. Cognitive slowing in Parkinson\u2019s disease is related to frontostriatal dopaminergic dysfunction. J Neurol Sci. 2013;329:23\u20138.","journal-title":"J Neurol Sci"},{"key":"3039_CR16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.410360209","volume":"36","author":"VA Holthoff","year":"1994","unstructured":"Holthoff VA, Vieregge P, Kessler J, et al. Discordant twins with Parkinson\u2019s disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol. 1994;36:176\u201382.","journal-title":"Ann Neurol"},{"key":"3039_CR17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-006-0357-2","volume":"34","author":"P Calvini","year":"2007","unstructured":"Calvini P, Rodriguez G, Inguglia F, et al. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging. 2007;34:1240\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3039_CR18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","volume":"36","author":"SA Eshuis","year":"2009","unstructured":"Eshuis SA, Jager PL, Maguire RP, et al. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson\u2019s disease and healthy controls. Eur J Nucl Med Mol Imaging. 2009;36:454\u201362.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3039_CR19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.neuroimage.2011.03.012","volume":"56","author":"N Pavese","year":"2011","unstructured":"Pavese N, Rivero-Bosch M, Lewis SJ, Whone AL, Brooks DJ. Progression of monoaminergic dysfunction in Parkinson\u2019s disease: a longitudinal 18F-dopa PET study. Neuroimage. 2011;56:1463\u20138.","journal-title":"Neuroimage"},{"key":"3039_CR20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/jnnp-2011-301818","volume":"83","author":"S Hirano","year":"2012","unstructured":"Hirano S, Shinotoh H, Eidelberg D. Functional brain imaging of cognitive dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2012;83:963\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3039_CR21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ. Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis. 2008;29:381\u201390.","journal-title":"Neurobiol Dis"},{"key":"3039_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neuroimage.2004.01.030","volume":"22","author":"A Nagano-Saito","year":"2004","unstructured":"Nagano-Saito A, Kato T, Arahata Y, et al. Cognitive- and motor-related regions in Parkinson\u2019s disease: FDOPA and FDG PET studies. Neuroimage. 2004;22:553\u201361.","journal-title":"Neuroimage"},{"key":"3039_CR23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neurobiolaging.2004.07.014","volume":"26","author":"A Br\u00fcck","year":"2005","unstructured":"Br\u00fcck A, Aalto S, Nurmi E, et al. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson\u2019s disease. Neurobiol Aging. 2005;26:891\u20138.","journal-title":"Neurobiol Aging"},{"key":"3039_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33\u20139.","journal-title":"Arch Neurol"},{"key":"3039_CR25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.2044-8295.1970.tb01248.x","volume":"61","author":"M Annett","year":"1970","unstructured":"Annett M. A classification of hand preference by association analysis. Br J Psychol. 1970;61:303\u201321.","journal-title":"Br J Psychol"},{"key":"3039_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","volume":"10","author":"S Katz","year":"1970","unstructured":"Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist. 1970;10:20\u201330.","journal-title":"Gerontologist"},{"key":"3039_CR27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179\u201386.","journal-title":"Gerontologist"},{"issue":"Suppl 3","key":"3039_CR28","first-page":"2","volume":"13","author":"G Deuschl","year":"1998","unstructured":"Deuschl G, Bain P, Brin M. Consensus statement of the movement disorder society on tremor. Ad hoc scientific committee. Mov Disord. 1998;13 Suppl 3:2\u201323.","journal-title":"Mov Disord"},{"key":"3039_CR29","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1212\/WNL.42.8.1554","volume":"42","author":"DJ Brooks","year":"1992","unstructured":"Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology. 1992;42:1554\u201360.","journal-title":"Neurology"},{"key":"3039_CR30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/mds.25849","volume":"29","author":"M Walterfang","year":"2014","unstructured":"Walterfang M, van de Warrenburg BP. Cognitive impairment in \"Other\" movement disorders: hidden defects and valuable clues. Mov Disord. 2014;29:694\u2013703.","journal-title":"Mov Disord"},{"key":"3039_CR31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/1073858409338217","volume":"15","author":"Y Kumakura","year":"2009","unstructured":"Kumakura Y, Cumming P. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Neuroscientist. 2009;15:635\u201350.","journal-title":"Neuroscientist"},{"key":"3039_CR32","first-page":"216","volume":"37","author":"T Ishikawa","year":"1996","unstructured":"Ishikawa T, Dhawan V, Chaly T, et al. Clinical significance of striatal DOPA decarboxylase activity in Parkinson\u2019s disease. J Nucl Med. 1996;37:216\u201322.","journal-title":"J Nucl Med"},{"key":"3039_CR33","first-page":"1324","volume":"43","author":"V Dhawan","year":"2002","unstructured":"Dhawan V, Ma Y, Pillai V, et al. Comparative analysis of striatal FDOPA uptake in Parkinson\u2019s disease: ratio method versus graphical approach. J Nucl Med. 2002;43:1324\u201330.","journal-title":"J Nucl Med"},{"key":"3039_CR34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","volume":"50","author":"P Jokinen","year":"2009","unstructured":"Jokinen P, Helenius H, Rauhala E, et al. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med. 2009;50:893\u20139.","journal-title":"J Nucl Med"},{"key":"3039_CR35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MNM.0b013e32835fcd7f","volume":"34","author":"A Jaimini","year":"2013","unstructured":"Jaimini A, Tripathi M, D\u2019Souza MM, et al. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson\u2019s disease from atypical parkinsonian disorders. Nucl Med Commun. 2013;34:426\u201331.","journal-title":"Nucl Med Commun"},{"key":"3039_CR36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00259-005-1904-y","volume":"33","author":"SA Eshuis","year":"2006","unstructured":"Eshuis SA, Maguire RP, Leenders KL, et al. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2006;33:200\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3039_CR37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1053-8119(03)00072-7","volume":"19","author":"JD Gispert","year":"2003","unstructured":"Gispert JD, Pascau J, Reig S, et al. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage. 2003;19:601\u201312.","journal-title":"Neuroimage"},{"key":"3039_CR38","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/brain\/awh150","volume":"127","author":"C Scherfler","year":"2004","unstructured":"Scherfler C, Khan NL, Pavese N, et al. Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain. 2004;127:1332\u201342.","journal-title":"Brain"},{"key":"3039_CR39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/jnnp.2004.055079","volume":"76","author":"AL Cheesman","year":"2005","unstructured":"Cheesman AL, Barker RA, Lewis SJ, et al. Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2005;76:1204\u201310.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3039_CR40","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1212\/01.wnl.0000187116.13370.e0","volume":"65","author":"N Oishi","year":"2005","unstructured":"Oishi N, Udaka F, Kameyama M, et al. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology. 2005;65:1708\u201315.","journal-title":"Neurology"},{"key":"3039_CR41","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/hbm.20718","volume":"30","author":"SB Eickhoff","year":"2009","unstructured":"Eickhoff SB, Laird AR, Grefkes C, et al. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp. 2009;30:2907\u201326.","journal-title":"Hum Brain Mapp"},{"key":"3039_CR42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnins.2013.00062","volume":"7","author":"SB Floresco","year":"2013","unstructured":"Floresco SB. Prefrontal dopamine and behavioral flexibility: shifting from an \"inverted-U\" toward a family of functions. Front Neurosci. 2013;7:62.","journal-title":"Front Neurosci"},{"key":"3039_CR43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnagi.2014.00164","volume":"6","author":"V Fleury","year":"2014","unstructured":"Fleury V, Cousin E, Czernecki V, et al. Dopaminergic modulation of emotional conflict in Parkinson\u2019s disease. Front Aging Neurosci. 2014;6:164.","journal-title":"Front Aging Neurosci"},{"key":"3039_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0166-2236(91)90179-X","volume":"14","author":"B Berger","year":"1991","unstructured":"Berger B, Gaspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci. 1991;14:21\u20137.","journal-title":"Trends Neurosci"},{"key":"3039_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neurobiolaging.2006.10.025","volume":"29","author":"S Tinaz","year":"2008","unstructured":"Tinaz S, Schendan HE, Stern CE. Fronto-striatal deficit in Parkinson\u2019s disease during semantic event sequencing. Neurobiol Aging. 2008;29:397\u2013407.","journal-title":"Neurobiol Aging"},{"key":"3039_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-013-1073-2","volume":"121","author":"U Ellfolk","year":"2014","unstructured":"Ellfolk U, Joutsa J, Rinne JO, et al. Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson\u2019s disease. J Neural Transm. 2014;121:33\u201340.","journal-title":"J Neural Transm"},{"key":"3039_CR47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0010-9452(08)70382-4","volume":"42","author":"MT Ullman","year":"2006","unstructured":"Ullman MT. Is Broca\u2019s area part of a basal ganglia thalamocortical circuit? Cortex. 2006;42:480\u20135.","journal-title":"Cortex"},{"key":"3039_CR48","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00259-011-1874-1","volume":"38","author":"F Nobili","year":"2011","unstructured":"Nobili F, Arnaldi D, Campus C, et al. Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38:2209\u201318.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3039_CR49","doi-asserted-by":"crossref","first-page":"e6102","DOI":"10.1371\/journal.pone.0006102","volume":"4","author":"D Tomasi","year":"2009","unstructured":"Tomasi D, Volkow ND, Wang R, et al. Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS One. 2009;4:e6102.","journal-title":"PLoS One"},{"key":"3039_CR50","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/brain\/awp166","volume":"132","author":"F Manganelli","year":"2009","unstructured":"Manganelli F, Vitale C, Santangelo G, et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson\u2019s disease. Brain. 2009;132:2350\u20135.","journal-title":"Brain"},{"key":"3039_CR51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(99)00127-6","volume":"166","author":"E Broussolle","year":"1999","unstructured":"Broussolle E, Dentresangle C, Landais P, et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson\u2019s disease. J Neurol Sci. 1999;166:141\u201351.","journal-title":"J Neurol Sci"},{"key":"3039_CR52","doi-asserted-by":"crossref","first-page":"206.e29","DOI":"10.1016\/j.neurobiolaging.2010.09.004","volume":"33","author":"C Polito","year":"2012","unstructured":"Polito C, Berti V, Ramat S, et al. Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson\u2019s disease. Neurobiol Aging. 2012;33:206.e29\u201339.","journal-title":"Neurobiol Aging"},{"key":"3039_CR53","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","volume":"74","author":"JC Klein","year":"2010","unstructured":"Klein JC, Eggers C, Kalbe E, et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology. 2010;74:885\u201392.","journal-title":"Neurology"},{"key":"3039_CR54","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/brain\/122.9.1637","volume":"122","author":"JS Rakshi","year":"1999","unstructured":"Rakshi JS, Uema T, Ito K, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson\u2019s disease. A 3D [(18)F]dopa-PET study. Brain. 1999;122:1637\u201350.","journal-title":"Brain"},{"key":"3039_CR55","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/brain\/124.6.1125","volume":"124","author":"V Kaasinen","year":"2001","unstructured":"Kaasinen V, Nurmi E, Br\u00fcck A, et al. Increased frontal [(18)F]fluorodopa uptake in early Parkinson\u2019s disease: sex differences in the prefrontal cortex. Brain. 2001;124:1125\u201330.","journal-title":"Brain"},{"key":"3039_CR56","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.20855","volume":"21","author":"A Br\u00fcck","year":"2006","unstructured":"Br\u00fcck A, Aalto S, Nurmi E, et al. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson\u2019s disease: a two-year follow-up study. Mov Disord. 2006;21:958\u201363.","journal-title":"Mov Disord"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3039-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3039-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:06:24Z","timestamp":1558713984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3039-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3039"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3039-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]}}}